Cardiac myoblasts, integral to the cardiovascular system, play a vital role in the intricate dance of heart functionality. As specialized muscle cells, they contribute significantly to cardiac development during embryogenesis, intricately weaving the essential muscle fibers that form the foundation for effective blood pumping. Beyond their critical role in heart development, these cells are garnering attention in the realm of regenerative medicine. Researchers are actively exploring the potential of cardiac myoblasts to serve as a regenerative force, particularly in the repair of damaged heart tissue. The unique ability of cardiac myoblasts to mature into functional cardiac muscle cells positions them as a promising avenue for therapeutic interventions, with the potential to revolutionize approaches to treating cardiovascular diseases. Ongoing studies in this field hold the key to uncovering innovative strategies that could redefine the landscape of cardiac regenerative medicine.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt